The fungal meningitis outbreak that began in the Fall of 2012 caused almost 1,000 illnesses across the country. Health officials conducted inspections of compounding pharmacies in Massachusetts, specifically the New England Compounding Center in Framingham, when they discovered the victims were treated with tainted spinal steroids produced by those companies. One of the facilities that is also in Kentucky and Tennessee, named PharMerica, has also been cited and was ordered to stop operations in December 2012. The Massachusetts Health Department found that the company did not follow proper procedure or controls in preparing the medications. There are a total of 40 compounding pharmacies in Massachusetts, 11 of which were ordered to “cease-and-desist” operations and another 21 facilities were cited for violations but allowed to continue productions. Inspections are ongoing and will continue until the pharmacies in question have addressed all contamination issues.